Probiotics and prebiotics have gotten a lot of attention in the scientific, healthcare, and public realms in recent years. Microbiome research has also widened the public image of microbes, moving away from disease-causing agents that should be avoided and toward a more reasonable approach that incorporates an appreciation of bacteria' beneficial roles in human health. As a result of these advancements, public awareness and acceptance of probiotics and prebiotics is growing, with probiotic industry growth predicted at 7% yearly and prebiotic growth forecast at 12.7 percent over the next eight years. New candidate probiotic strains will not just come from the gut microbiome. The female urogenital tract, mouth cavity, nasopharyngeal tract, and skin are all areas of great interest for novel species discovery and action. Emerging healthcare concerns will spur research into new areas of global health importance, and a growing body of evidence for essential applications will help policymakers and practitioners make better decisions.
Title : Results from a cross-sectional observational study examining irritable bowel syndrome patients six months after finishing their participation in the ViIBS trial
Jacek Piatek, Calisia University, Poland
Title : Gut microbiome as a driver of healthy ageing
Thi Thu Hao Van, RMIT University, Australia
Title : Treating irritable bowel syndrome patients with a balanced multi-strain synbiotic–results from a multi-center, randomized, double-blind, placebo-controlled clinical trial (the ViIBS trial)
Henning Sommermeyer, Calisia University, Poland
Title : Molecular mechanisms underlying the anti-atherogenic actions of probiotics
Dipak P Ramji, Cardiff University, United Kingdom
Title : Global regulatory trends on the use of probiotics and prebiotics in foods and food supplements
David Pineda Ereno, DPE International Consulting, Belgium
Title : Biochemical profile and nutripotential glimpses of Terminalia arjuna bark extract
Suriyavathana Muthukrishnan, Periyar University, India